NASDAQ:ZLAB
Zai Lab Ltd Stock News
$15.91
+0.170 (+1.08%)
At Close: Apr 26, 2024
You've Probably Never Heard of the Stock Market's Biggest Winner Wednesday
01:24pm, Wednesday, 11'th Nov 2020
And as a bonus, find out which much-loved stock let its shareholders down.
SHANGHAI and SAN FRANCISCO, Nov. 10, 2020 (GLOBE NEWSWIRE) -- Zai Lab Limited's (NASDAQ: ZLAB; HKEX: 9688) partner Five Prime Therapeutics, Inc. (NASDAQ: FPRX), a clinical-stage biotechnology company
Week In Review: CStone Out-Licenses Ex-China Rights To 2 Immunotherapies In $1.3 Billion Deal
02:28pm, Sunday, 01'st Nov 2020
CStone Pharma out-licensed global rights (ex-China) for two immuno-oncology assets to US-based EQRx in a $1.3 billion agreement. CASI Pharma in-licensed China rights to a novel antibody checkpoint rec
Zai Lab Announces First Patient Dosed in China in a Potentially Registrational Study of Retifanlimab in Patients with Endometrial Cancer
07:30am, Thursday, 29'th Oct 2020
SHANGHAI and SAN FRANCISCO, Oct. 29, 2020 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688), an innovative commercial stage biopharmaceutical company, today announced dosing of the first
Zai Lab Announces Upcoming Presentations in November Investor Conferences
07:30am, Wednesday, 28'th Oct 2020
SHANGHAI and SAN FRANCISCO, Oct. 28, 2020 (GLOBE NEWSWIRE) -- Zai Lab Limited (“Zai Lab”) (NASDAQ: ZLAB; HKEX: 9688), an innovative commercial stage biopharmaceutical company, today announced that
